MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Cytosorbents Corporation Market Cap 2011-2026 | CTSO
As of February 26, 2026 Cytosorbents Corporation has a market cap of $ 39.7 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Cytosorbents Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.4 M | 44.7 M | 157 M | 161 M | 407 M | 160 M | 227 M | 210 M | 141 M | 95.6 M | 115 M | 66.1 M | 20.8 M | 23.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 407 M | 20.8 M | 135 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 13.76 | -2.03 % | $ 2.06 B | USA |
 |
ClearPoint Neuro
CLPT
|
466 M | $ 13.41 | -11.54 % | $ 362 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 31.45 | 0.72 % | $ 1.45 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
661 M | $ 6.9 | 4.23 % | $ 495 M |  Israel |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 4.6 | 0.22 % | $ 172 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.39 | -1.02 % | $ 117 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
175 M | $ 24.07 | 1.26 % | $ 203 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 272.0 | 0.95 % | $ 7.67 B | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 40.37 | 1.19 % | $ 6.02 K | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 75.2 | 2.35 % | $ 111 B | USA |
 |
InMode Ltd.
INMD
|
928 M | $ 13.95 | -0.07 % | $ 902 M | Israel |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.46 | -2.67 % | $ 23.5 M | USA |
 |
IRadimed Corporation
IRMD
|
670 M | $ 100.95 | 0.45 % | $ 1.28 B | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 46.36 | 0.85 % | $ 1.44 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 70.67 | 0.54 % | $ 3.85 B |  Britain |
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
111 B | $ 96.65 | -0.01 % | $ 124 B | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 5.01 | -5.02 % | $ 740 M | USA |
 |
Delcath Systems
DCTH
|
375 M | $ 9.09 | -11.02 % | $ 259 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.46 | 0.2 % | $ 144 M | Israel |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
1.2 B | $ 75.58 | -3.46 % | $ 2.13 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
18.1 B | $ 250.88 | 1.11 % | $ 17.6 B | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Quanterix Corporation
QTRX
|
893 M | $ 6.35 | 0.95 % | $ 239 M | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.53 | -0.27 % | $ 121 M | USA |
 |
Sintx Technologies
SINT
|
187 K | $ 2.9 | 0.14 % | $ 10.8 M | USA |